Efficacy and safety of raltitrexed-based transcatheter arterial chemoembolization for intermediate and advanced hepatocellular carcinoma: A multicenter real-world study.
Jiahui HeHang SunFei LiHao YangMinggeng LouShunde WangChuanxin WuPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2021)
Raltitrexed-based TACE can prolong the OS of patients with intermediate and advanced HCC in a real-world clinical setting, and is safe and tolerable.
Keyphrases